Cellular immune responses against proinsulin: No evidence for enhanced reactivity in individuals with IDDM

Diabetes

Volumn 48, Issue 2, 1999, Pages 299-303

  Ellis, Tamir ^a   Jodoin, Eric ^a   Ottendorfer, Eric ^a   Salisbury, Patricia ^a   She, Jin Xiong ^a   Schatz, Desmond ^a   Atkinson, Mark A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROINSULIN;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0032968699     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.2.299     Document Type: Article

References (39)

1. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes. N Engl J Med 331:1428-1436, 1994
2. Bach J-F: Insulin-dependent diabolos as an autoimmune disease. Endocr Rev 14:516-542, 1994
3. Roep BO: T-cell responses to autoantigens in IDDM: the search for the Holy Grail. Diabetes 45:1147-1156, 1996
4. Kontiainen S, James RL, Feldmann M: Human islet cell induced T-cell lines and clones from diabetic children. Autoimmunity 8:193-197, 1991
5. Harrison LC, De Aizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD, Colman PG: Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 40:1128-1133, 1991
6. Durinovic-Bello I, Hummel M, Ziegler AG: Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45:795-800, 1996
7. Roep BO, Kallan AA, Hazenbos WLW, Bruining GJ, Baileys EM, Arden SD, Hutton JC, De Vries RRP: T-cell reactivity to 38kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet. 337:1439-1441, 1991
8. Honeymoon MC, Cram DS, Harrison LC: Transcription factor jun-B is a target of autoreactive T-cells in IDDM. Diabetes 42:631-636, 1993
9. Roep BO, Duinkerken G, Schreuder GMT, Kolb H, De Vries RRP, Martin S: HLA-associatod inverse correlation between T-cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 26:1285-1289, 1996
10. Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, She JX, Notkins AL, Maclaren NK, Atkinson MA: The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes 47:566-569, 1998
11. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu D-F, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 337:458-459, 1992
12. Honeymoon MC, Cram DS, Harrison LC: Glutamic acid decarboxylase 67-reactive T-cells: a marker of insulin-dependent diabetes. J Exp Med 177:535-540, 1993
13. Harrison LC, Honeymoon MC, De Aizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relations between humoral and cellular immunity to glutamic acid decarbolxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
14. Keller RJ: Cellular immunity to human insulin in individuals at high risk for the development of type 1 diabetes mellitus. J Autoimmunity 3:321-327, 1990
15. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS: Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40:564-572, 1997
16. Rudy G, Stone N, Harrison LC, Colman PG, McNair P, Brusic V, French MB, Honeymoon MG, Tait B, Lew AM: Similar peptides from two β-cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T-cells of individuals at risk for insulin-dependent diabetes. Mol Med 1:625-633, 1995
17. Hummel M, Durinovic-Bello I, Ziegler AG: Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J Autoimmunity 9:427-430, 1996
18. Harrison LC: Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 13:348-352, 1992
19. Atkinson MA, Maclaren NK: Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 92:1608-1616, 1993
20. Ziegler AG, Hillebrand B, Rabl W, Mayhofer M, Hummel M, Mollenhauer U, Vordemann J, Lenz A, Standl E: On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia 36:402-408, 1994
21. Heaton DA, Millward BA, Bray IP: Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients. Diabetologia 31:182-184, 1988
22. Spinas GA, Snorgaard O, Harrling SG, Oberholzer M, Berger W: Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients. Diabetes Care 15:632-637, 1992
23. Lindgren GA, Hartling SG, Persson BE: Proinsulin levels in newborn siblings of type 1 (insulin-dependent) diabetic children and their mothers. Diabetologia 36:560-563, 1993
24. Kuglin B, Gries FA, Kolb H: Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 37:130-132, 1988
25. Kuglin V, Holder B, Bertrams J, Gruneklee D, Gries FA, Kolb H: Proinsulin autoantibodies: association with type 1 diabetes but not with islet cell antibodies, insulin autoantibodies or HLA-DR type. J Autoimmun 3:573-577, 1990
26. French MB, Allison J, Cram DS, Thomas HE, Cempsey-Collier M, Silva A, Georgious HM, Kay TW, Harrison LC, Lew AM: Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46:40-43, 1977
27. Schatz DS, Krischer J, Home G, Riley WJ, Winter WE, Silverstein JH, Allen L, Shah S, Malone J, Maclaren NK: Islet cell antibodies predict the development of insulin-dependent diabetes in United States schoolchildren as effectively as in unaffected relatives. J Clin Invest 93:2403-2407, 1994
28. Atkinson MA, Bowman MA, Kao KJ, Dush PD, Simmel O, Maclaren NK: Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 329:1853-1858, 1993
29. Ellis TM, Ottendorfer E, Jodoin E, Salisbury PJ, She JX, Schatz DA, Atkinson MA: Cellular immune responses to β casein: elevated in but not specific for individuals with type I diabetes mellitus. Diabetalogia 41:731-735, 1998
30. Bieganowska KD, Ausubel LJ, Modabber Y, Slovik E, Messersmith W, Hafler DA: Direct ex vivo analysis of activated, fas-sensitive autoreactive T-cells in human autoimmune disease. J Exp Med 185:1585-1594, 1997
31. Cheung R, Karjalainen J, Vandermeulen J, Singal DP, Dosch HM: T-cells from children with IDDM and sensitized to bovine serum albumin. Scared J Immunol 623-628, 1994
32. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD: The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293-297, 1997
33. Wegmann DR, Norbury-Glasser M, Daniel D: Insulin-specific T-cells are apredominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 24:1853-1857, 1994
34. Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T-cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062, 1995
35. Atkinson MA, Maclaren NK, Luchetta R: Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-937, 1990
36. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256, 1991
37. Muir A, Peck A, Clare-Salzler M, Song YH, Cornelius J, Luchetta R, Maclaren NK: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 95:628-634, 1995
38. Karounos DG, Bryson JS, Cohen DA: Metabolically inactive insulin analog prevents type 1 diabetes in prediabetic NOD mice. J Clin Invest 100:1-5, 1997
39. Eisenbarth GS, Verge CF, Allen H, Rewers MJ: The design of trials for prevention of IDDM. Diabetes 42:941-947, 1993